vimarsana.com

Latest Breaking News On - China medical healthcare group - Page 1 : vimarsana.com

Hong Kong Regulatory Update - July 2021 | Skadden, Arps, Slate, Meagher & Flom LLP

HKEx Announces Move to T+2 IPO Settlement Under FINI Plan HKEx has announced that it will proceed moving IPOs to a “T+2” settlement timetable under its “Fast Interface for New Issuance” (FINI) plan. This shift is a slight change to the original T+1 settlement plans proposed in the HKEx concept paper published in November 2020, but nevertheless a significant improvement on the current process, which generally results in IPOs in Hong Kong settling on a T+5 basis. The plan will require IPOs to follow the new T+2 timetable unless a company obtains a waiver from HKEx. The new timetable requires that:

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.